Dimensional Fund Advisors
HARP

Dimensional Fund Advisors’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Dimensional Fund Advisors’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,812
Closed -$66K – 3529
2022
Q3 		$66K Sell
6,812
-1,611
-19% -$30.1K ﹤0.01% 3376
2022
Q2 		$161K Sell
8,423
-1,904
-18% -$49.3K ﹤0.01% 3275
2022
Q1 		$513K Buy
10,327
+3,458
+50% +$179K ﹤0.01% 3142
2021
Q4 		$519K Buy
6,869
+82
+1% +$5.6K ﹤0.01% 3158
2021
Q3 		$536K Sell
6,787
-2,661
-28% -$267K ﹤0.01% 3164
2021
Q2 		$1.31M Buy
9,448
+6,509
+221% +$1.24M ﹤0.01% 2977
2021
Q1 		$615K Sell
2,939
-130
-4% -$26.1K ﹤0.01% 3103
2020
Q4 		$510K Sell
3,069
-69
-2% -$10.7K ﹤0.01% 3091
2020
Q3 		$532K Buy
3,138
+1,002
+47% +$145K ﹤0.01% 3046
2020
Q2 		$354K Buy
+2,136
New +$333K ﹤0.01% 3135

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Dimensional Fund Advisors's HARP Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022, closing a stake of 6,812 shares — an estimated $66K sold.

Dimensional Fund Advisors first reported a position in HARP in Q2 2020 and held it in 10 quarters. The position peaked at $1.31M in Q2 2021. 49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 6,812 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $66K.
  • Dimensional Fund Advisors first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Dimensional Fund Advisors's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.31M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.